Evidera
Marie Andrawes began their work experience in 2008 as a Postdoctoral Researcher at the Dana-Farber Cancer Institute, where they worked until November 2013. In 2015, they joined Evidera as a Market Access Medical Writer and later progressed to roles such as Senior Market Access Writer, Lead Market Access Writer, and Associate Director of Market Access Communications. Currently, Marie holds the position of Director of Market Access Communications at Evidera, starting in April 2021.
Marie Andrawes pursued their education in the field of science, starting with a Bachelor of Science (B.S.) degree in Chemistry from the Massachusetts Institute of Technology. Marie attended this institution from 1997 to 2001. Following their undergraduate studies, Marie Andrawes continued to further their knowledge and expertise by enrolling at Duke University. Marie obtained a Doctor of Philosophy (PhD) degree in Pharmacology from 2001 to 2008. Marie Andrawes' educational background demonstrates their commitment to expanding their understanding in the scientific disciplines of chemistry and pharmacology.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.